Two calix[4]pyrroles as potential therapeutics for castration-resistant prostate cancer.
Toumia IB, Ponassi M, Barboro P, Iervasi E, Vargas GC, Banelli B, Fiordoro S, Ghedira LC, Kohnke FH, Izzotti A, Rosano C.
Toumia IB, et al. Among authors: ghedira lc.
Invest New Drugs. 2022 Dec;40(6):1185-1193. doi: 10.1007/s10637-022-01294-8. Epub 2022 Aug 17.
Invest New Drugs. 2022.
PMID: 35976541